Special Issue "Bioprospecting of Marine Microorganisms"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: 1 January 2019
Microorganisms are leading sources of novel compounds that have been used in the pharmaceutical industry since their discovery. Several bacterial and fungal classes are capable of synthesizing various classes of secondary metabolites. The diversity in their chemical structures (alkaloids, polyketides, peptides and terpenes), as well as their bioactivities (antifungal, antibacterial, antiviral, antiparasitic, immunomodulatory, antioxidant, anti-inflammatory, and anticancer) highlight their role in pharmaceutical and agricultural research. Since the discovery of penicillin in 1928, several microorganism-derived antibiotics have been discovered and the recent example is teixobactin. Teixobactin was identified by Ling and coworkers from a soil microorganism (provisionally named Eleftheria terrae) and represent a new class of antibiotics. The presence in those extreme environmental conditions, such as high pressure, lack of light, salinity and pH, provoke marine microorganisms to biosynthesize a unique variety of chemicals, of which a large number are still unexplored in comparison to their terrestrial counterparts, and can become a source of bioactive lead compounds.
This Special Issue “Bioprospecting of Marine Microorganisms” in Marine Drugs will cover the scope of natural products derived from marine microorganisms. Phylogenetic and diversity studies as well as new methodologies for isolating marine microorganisms will also be targeted in this Special Issue.
As Guest Editor, I encourage all researchers who are interested in marine research to contribute their latest research findings in this area. I hope that it will help to gain more knowledge about marine microorganisms as a leading source for drug discovery.
Prof. Usama Ramadan Abdelmohsen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Marine microorganisms
- Natural products
- Marine actinomycetes
- Marine fungi
- Drug discovery
- Structure elucidation